Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4554922016 | Trilaciclib dihydrochloride | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4554923014 | Trilaciclib dihydrochloride (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Trilaciclib dihydrochloride | Is modification of (attribute) | Trilaciclib (substance) | true | Inferred relationship | Some | ||
| Trilaciclib dihydrochloride | est un(e) (attribut) | Pyrrole | true | Inferred relationship | Some | ||
| Trilaciclib dihydrochloride | est un(e) (attribut) | Antineoplastic agent (substance) | true | Inferred relationship | Some | ||
| Trilaciclib dihydrochloride | Has disposition (attribute) | Protein kinase inhibitor (disposition) | true | Inferred relationship | Some | ||
| Trilaciclib dihydrochloride | est un(e) (attribut) | Protein kinase inhibitor | true | Inferred relationship | Some | ||
| Trilaciclib dihydrochloride | est un(e) (attribut) | Enzyme inhibitor | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely trilaciclib (as trilaciclib dihydrochloride) 300 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) | Has precise active ingredient | False | Trilaciclib dihydrochloride | Inferred relationship | Some | 1 |
| Trilaciclib (as trilaciclib dihydrochloride) 300 mg powder for solution for injection vial | Has precise active ingredient | True | Trilaciclib dihydrochloride | Inferred relationship | Some | 1 |
This concept is not in any reference sets
FHIR